Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PSA | Common Shares | Options Exercise | $8.6M | +53.3K | +30.58% | $161.42 | 227K | Dec 12, 2023 | Direct | F1 |
transaction | PSA | Common Shares | Sale | -$9.16M | -33.6K | -14.76% | $272.82 | 194K | Dec 12, 2023 | Direct | F1, F2 |
transaction | PSA | Common Shares | Sale | -$5.38M | -19.7K | -10.16% | $273.23 | 174K | Dec 12, 2023 | Direct | F1, F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PSA | Stock Option (Right to Buy) | Options Exercise | $0 | -53.3K | -100% | $0.00* | 0 | Dec 12, 2023 | Common Shares | 53.3K | $161.42 | Direct | F4, F5 |
Id | Content |
---|---|
F1 | Includes 17,300 restricted stock units and 2,207 deferred stock units. |
F2 | Represents weighted average price. These shares were sold at prices ranging between $272.58 and $272.99. Full information regarding the number of shares sold at each separate price will be provided by the reporting person upon request to the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer. |
F3 | Represents weighted average price. These shares were sold at prices ranging between $273.00 and $273.82. Full information regarding the number of shares sold at each separate price will be provided by the reporting person upon request to the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer. |
F4 | Stock option granted pursuant to the 2007 Equity and Performance-Based Incentive Compensation Plan. Option vests in five (5) equal annual installments beginning one (1) year from grant date. |
F5 | This option was previously reported as an option for 100,000 common shares at an exercise price of $166.71, but, pursuant to anti-dilution provisions of the Company's 2007 Equity and Performance-Based Incentive Compensation Plan, was adjusted to reflect the special dividend declared by the Company on July 22, 2022. Of the 103,275 common shares underlying the as-adjusted option, the reporting person previously reported the exercise of this option as to 50,000 common shares, and the exercise reported on this Form 4 reflects the exercise of the remainder of the option. |